Supervalu sells Bristol Farms division
MINNEAPOLIS Supervalu has sold 14 stores under the Bristol Farms banner, the retailer announced Friday.
The division was sold to a company formed through a partnership with the Bristol Farms management team and Endeavour Capital, an investment firm experienced in grocery and retail businesses. Under the terms of the sale, the stores will change ownership effective Friday, but will continue to operate under the Bristol Farms name, and the existing management and associate base will continue to serve customers without disruption.
“Supervalu continuously evaluates its operations to identify opportunities to strengthen its overall business and, when necessary, makes decisions that involve the sale of some locations,” said Brian Huff, Supervalu SVP specialty retail. “This move will ultimately allow Supervalu to operate more efficiently and effectively, and focus on improving the shopping experience throughout its entire network of owned and supplied stores.”
FDA OKs expanded use of Sprycel
SILVER SPRING, Md. The Food and Drug Administration has approved a new usage for a blood cancer drug, the agency said Thursday.
The FDA approved Bristol-Myers Squibb’s Sprycel (dasatinib) for treating chronic phase chronic myeloid leukemia that contains the so-called Philadelphia chromosome, also called Ph+ CP-CML. The FDA originally approved the drug in June 2006 for patients with CP-CML for whom treatment with Novartis’ Gleevec (imatinib) had failed. CML results from an overabundance of blood stem cells developing into abnormal forms of white blood cells called granulocytes, which build up in the blood and bone marrow and crowd out healthy white and red blood cells and platelets, creating risk for infections, anemia and unexpected bleeding.
“These drugs have dramatically changed the lives of patients with CML,” FDA Office of Oncology Drug Products director Richard Pazdur said. “Results from additional CML studies continue to demonstrate the importance of studying cancer drugs in the earlier stages of the disease.”
Bic improves its pens with new technology
SHELTON, Conn. Bic celebrated the official launch of its Easy-Glide System ink technology, which has been incorporated into its Velocity retractable, Atlantis retractable and Pro+ ball pens.
The technology provides up to 35% smoother writing compared with current Bic pen ink systems, the company said.
To help celebrate the event, Bic is kicking off its "Get a Clue" event Nov. 3 and 4 at Vanderbilt Hall in Grand Central Terminal, which invites consumers to help solve a gigantic crossword puzzle and learn more about how Bic ballpoint pens are made.
"This event is a fun way for commuters, many of whom do crossword puzzles during their train ride to Manhattan each day, to spend a few minutes to help us complete a gigantic crossword puzzle," said Joseph Franzino, senior brand manager at Bic Consumer Products USA, a division of Bic USA. "In addition to the crossword puzzle and free samples of the Bic Velocity retractable ball pen, commuters will also receive coupons for Bic stationery products and have the chance to receive free giveaways and participate in a fun sensory box activity to see how smooth they are at guessing what is in the boxes."